Erytech Pharma
(NASDAQ:ERYP)
$0.6001
-0.0051[-0.84%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$0.65
0.0499[8.32%]
After Hours: 4:02PM EDT
Day Range0.55 - 0.652 Wk Range- - 2.99Open / Close0.55 / 0.6Float / Outstanding- / 31M
Vol / Avg.8.2K / 15.1KMkt Cap18.6MP/E-50d Avg. Price0.63
Div / Yield-Payout Ratio-Total Float-EPS-0.17

Erytech Pharma Stock (NASDAQ:ERYP), Quotes and News Summary

Erytech Pharma Stock (NASDAQ: ERYP) stock price, news, charts, stock research, profile.

Loading...
Day Range0.55 - 0.652 Wk Range- - 2.99Open / Close0.55 / 0.6Float / Outstanding- / 31M
Vol / Avg.8.2K / 15.1KMkt Cap18.6MP/E-50d Avg. Price0.63
Div / Yield-Payout Ratio-Total Float-EPS-0.17
InvestorsObserver - Nov 22, 2022, 10:38AM
Seeking Alpha - Oct 13, 2022, 4:28PM
InvestorsObserver - Apr 26, 2022, 6:44AM
InvestorPlace - Apr 25, 2022, 4:28PM
Seeking Alpha - Apr 25, 2022, 8:39AM
Seeking Alpha - Dec 14, 2021, 1:47AM
Sector: Health Care.Industry: Biotechnology
Erytech Pharma SA is a clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases. Its ERYCAPS platform, uses a novel technology to encapsulate therapeutic drug substances inside erythrocytes, or red blood cells, or RBC. It is developing a pipeline of product candidates for patients with high unmet medical needs. Its lead product candidate eryaspase, also referred as GRASPA, targets the metabolism of cancer cells by depriving the cells of asparagine, an amino acid necessary for their survival and critical in maintaining the cells' rapid growth rate. The company is developing eryaspase for the treatment of severe tumors, including pancreatic cancer, acute lymphoblastic leukemia, or ALL, and triple negative breast cancer, or TNBC.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
REV
H1 2022Est.ActualSurprise
EPS-0.030
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Erytech Pharma (ERYP) stock?

A

You can purchase shares of Erytech Pharma (NASDAQ: ERYP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Erytech Pharma's (ERYP) competitors?

Q

What is the target price for Erytech Pharma (ERYP) stock?

A

The latest price target for Erytech Pharma (NASDAQ: ERYP) was reported by JMP Securities on Thursday, September 5, 2019. The analyst firm set a price target for 13.00 expecting ERYP to rise to within 12 months (a possible 2066.31% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Erytech Pharma (ERYP)?

A

The stock price for Erytech Pharma (NASDAQ: ERYP) is $0.6001 last updated Today at November 30, 2022, 5:30 PM UTC.

Q

Does Erytech Pharma (ERYP) pay a dividend?

A

There are no upcoming dividends for Erytech Pharma.

Q

When is Erytech Pharma (NASDAQ:ERYP) reporting earnings?

A

Erytech Pharma’s Q3 earnings are confirmed for Monday, November 21, 2022.

Q

Is Erytech Pharma (ERYP) going to split?

A

There is no upcoming split for Erytech Pharma.

Q

What sector and industry does Erytech Pharma (ERYP) operate in?

A

Erytech Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.